Research2Guidance November 19, 2025
Medication companion apps used to sit on the fringes of digital health. Today, they are moving straight into the center of pharma’s commercial and clinical strategies. What started as simple reminder tools has turned into a fast-expanding digital layer that influences prescribing, adherence, real-world evidence generation, and long-term therapy outcomes.
The shift is not subtle. Research2Guidance’s 2025 Companion App Report shows that around 300 active companion apps support branded therapies today. That number will pass 3,000 by 2029. Even then, only 2.5 percent of global drug portfolios will offer a digital companion, which means the market is both underdeveloped and poised for explosive growth.
For pharma, the logic is simple: companion apps sit at the intersection of patient support, evidence...
Today's Sponsors
Today's Sponsor